Cargando…

Cost-effectiveness analysis for clinicians

In a climate of economic uncertainty, cost effectiveness analysis is a potentially important tool for making choices about health care interventions. Methods for such analyses are well established, but the results need to be interpreted carefully and are subject to bias. Making decisions based on re...

Descripción completa

Detalles Bibliográficos
Autor principal: Hill, Suzanne R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395827/
https://www.ncbi.nlm.nih.gov/pubmed/22296610
http://dx.doi.org/10.1186/1741-7015-10-10
_version_ 1782238040492605440
author Hill, Suzanne R
author_facet Hill, Suzanne R
author_sort Hill, Suzanne R
collection PubMed
description In a climate of economic uncertainty, cost effectiveness analysis is a potentially important tool for making choices about health care interventions. Methods for such analyses are well established, but the results need to be interpreted carefully and are subject to bias. Making decisions based on results of cost-effectiveness analyses can involve setting thresholds, but for individual patients, there needs to be disaggregation of benefits and harms included in a quality adjusted life year to ensure appropriate consideration of benefits and harms as well as personal preferences and circumstances.
format Online
Article
Text
id pubmed-3395827
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33958272012-07-14 Cost-effectiveness analysis for clinicians Hill, Suzanne R BMC Med Commentary In a climate of economic uncertainty, cost effectiveness analysis is a potentially important tool for making choices about health care interventions. Methods for such analyses are well established, but the results need to be interpreted carefully and are subject to bias. Making decisions based on results of cost-effectiveness analyses can involve setting thresholds, but for individual patients, there needs to be disaggregation of benefits and harms included in a quality adjusted life year to ensure appropriate consideration of benefits and harms as well as personal preferences and circumstances. BioMed Central 2012-02-01 /pmc/articles/PMC3395827/ /pubmed/22296610 http://dx.doi.org/10.1186/1741-7015-10-10 Text en Copyright ©2012 Hill; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Hill, Suzanne R
Cost-effectiveness analysis for clinicians
title Cost-effectiveness analysis for clinicians
title_full Cost-effectiveness analysis for clinicians
title_fullStr Cost-effectiveness analysis for clinicians
title_full_unstemmed Cost-effectiveness analysis for clinicians
title_short Cost-effectiveness analysis for clinicians
title_sort cost-effectiveness analysis for clinicians
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395827/
https://www.ncbi.nlm.nih.gov/pubmed/22296610
http://dx.doi.org/10.1186/1741-7015-10-10
work_keys_str_mv AT hillsuzanner costeffectivenessanalysisforclinicians